Minot Light Capital’s Largest Performance Detractor in Q4: Journey Medical (DERM)
Minot Light Capital, an investment management firm, recently released its fourth-quarter 2024 investor letter. A copy of the ...
来自MSN4 天
Why It's Hard for Patients to Get the Newest Alzheimer's Drugs
Fact checked by Nick Blackmer Two Alzheimer's drugs that target amlyoid plaques have been approved for months, but many hospitals are only now starting to offer these treatments. Leqembi ...
Akeso, Inc.: Cadonilimab (PD-1/CTLA-4) Phase III Data for First Line Treatment of Advanced ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine ...
Orphan Drugs Strategic Business Report 2024-2030: Biologics, Oncology & Hospital Pharmacies ...
Orphan Drugs Market Orphan Drugs Market Dublin, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The "Orphan Drugs - Global Strategic ...
Le Lézard6 天
Precision Diagnostics & Medicine Market worth $246.66 billion by 2029 with 11.1% CAGR ...
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of 11.1%, reaching US$145.53 billion in 2024 and an impressive US$246.